Table: Daito -Q1 group results
Oct 8 (Reuters)-
Daito Pharamaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Aug 31, 2015 Aug 31, 2014 May 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.73 7.42 37.00
(+17.7 pct) (+5.1 pct) (+8.6 pct)
Operating 968 mln 717 mln 3.55
(+35.0 pct) (+9.9 pct) (+0.9 pct)
Recurring 1.01 715 mln 3.50
(+40.9 pct) (+7.7 pct) (+1.4 pct)
Net 678 mln 456 mln 2.30
(+48.6 pct) (+13.1 pct) (+2.4 pct)
EPS 54.23 yen 40.00 yen 183.78 yen
Ann Div 30.00 yen 30.00 yen
-Q2 div 15.00 yen 15.00 yen
-Q4 div 15.00 yen 15.00 yen
NOTE - Daito Pharamaceutical Co Ltd .
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Daito Pharmaceutical
See all newsTo Buy Back Up To 4.4% Of Own Shares Worth 2 Billion Yen
Table: Daito Pharmaceutical -Q1 group results
Execution Of JV And Share Transfer Agreement For Transfer Of Kyorin Pharmaceutical's Generic Drug Business To JV By Daito, Meiji Seika Pharma And Dbj
Table: Daito -2025/26 parent results
Table: Daito -2025/26 group results